Position in NVAX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$518,618
+$64,813 QoQ
Shares Held
55,055
-1.2% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $124,479,036 across 113 Biotechnology names. NVAX ranks #42 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
50,813 | $25,240,341 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
186,987 | $10,273,065 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,671 | $9,147,955 | |
| 4 | EXEL |
Exelixis, Inc.
|
105,998 | $5,767,351 | |
| 5 | TARS |
Tarsus Pharmaceuticals, Inc.
|
79,888 | $5,028,150 | |
| 6 | MRNA |
Moderna, Inc.
|
66,546 | $4,660,216 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
12,116 | $4,503,153 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
55,170 | $4,496,906 |
All Filings in NVAX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $518,618 | 55,055 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $453,805 | 55,750 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $336,658 | 50,098 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $435,858 | 50,272 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $353,196 | 56,063 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $323,833 | 50,520 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $345,993 | 43,034 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $502,648 | 39,798 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $549,912 | 43,437 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $308,878 | 64,619 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $87,878 | 18,308 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $125,302 | 17,307 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $112,237 | 15,106 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $92,148 | 13,297 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $136,847 | 13,312 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $209,445 | 11,508 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $679,441 | 13,211 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $822,007 | 11,161 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,826,145 | 12,764 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $2,610,654 | 12,593 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $2,090,616 | 9,847 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,746,740 | 9,634 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,421,864 | 12,751 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,674,440 | 15,454 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $823,247 | 9,877 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $198,091 | 14,587 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||